.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Dow
Julphar
Teva
Argus Health
Moodys
Covington
Novartis
Accenture
US Army

Generated: July 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077030

« Back to Dashboard
NDA 077030 describes CILOSTAZOL, which is a drug marketed by Breckenridge Pharm, Frontida Biopharm, Sandoz, Mylan Pharms Inc, Ivax Sub Teva Pharms, Biokey, Epic Pharma Llc, Mylan, West-ward Pharms Int, Teva, Actavis Elizabeth, Apotex Inc, and Pliva Hrvatska Doo, and is included in sixteen NDAs. It is available from nineteen suppliers. Additional details are available on the CILOSTAZOL profile page.

The generic ingredient in CILOSTAZOL is cilostazol. There are twelve drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the cilostazol profile page.

Summary for NDA: 077030

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Blood Products/Modifiers/ Volume Expanders
Formulation / Manufacturing:see details

Pharmacology for NDA: 077030

Suppliers and Packaging for NDA: 077030

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CILOSTAZOL
cilostazol
TABLET;ORAL 077030 ANDA Lake Erie Medical DBA Quality Care Products LLC 35356-951 35356-951-30 30 TABLET in 1 BOTTLE (35356-951-30)
CILOSTAZOL
cilostazol
TABLET;ORAL 077030 ANDA AvPAK 50268-176 50268-176-15 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-176-15) > 1 TABLET in 1 BLISTER PACK (50268-176-11)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Dec 10, 2004TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:Dec 10, 2004TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
McKinsey
UBS
Boehringer Ingelheim
Express Scripts
Daiichi Sankyo
Teva
Merck
Medtronic
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot